A balance model of milk synthesis was developed. The model balances carbon flow into and out of the gland and generates sufficient energy and reducing equivalents to meet synthetic requirements.
INTRODUCTION
Investigations of physiological and biochemical processes in lactating mammary glands have provided an understanding of most aspects of milk synthesis (45, 53, 67) . Even so, no attempt has been made to integrate these processes into a mathematical model of milk synthesis to evaluate current information for adequacy in the quantitative and dynamic (kinetic) domains nor to utilize this information effectively in selection, design, and interpretation of further experiments (9) . Objectives were to integrate available information relevant to nutrient uptake and output by the mammary gland, to reconcile these in the form of a balance model depicting the biochemistry of milk synthesis, to convert the balance model into a dynamic model that accommodates radioisotope tracer and kinetic data, and finally to utilize the model to identify and interpret additional experiments.
GENERAL CONSIDERATIONS
The model was calculated to represent a 650-kg Holstein cow fed a standard diet and producing 15 kg milk per day. Milk production was set low (15 kg/day) because most in vivo and in vitro data relate to this amount of production. Udder weight was set at 21.7 kg (65) and was compartmentalized into intracellular space (80% or 17.3 kg) and extracellular space (20% or 4.3 kg; 33) to enable calculation of metabolite pool sizes (Table 6 ).
Milk Composition
Milk composition was set at 4.8% lactose, 3.5% fat, 3.6% crude protein, and .17% citrate. Minor constituents including lactic, formic, acetic, and propionic acids make up .014% of milk (40) and were ignored.
Composition of milk fat is in Table 1 . All milk fat was assumed to be in the form of triacylglycerol (TG; 40) .
Crude protein (CP) content of milk is routinely determined by multiplying content by 6.38 (40, 42) . The CP includes approximately 4.4% nonprotein nitrogen and 5% proteose peptones (40) . All true proteins in milk are synthesized by the gland except albumin and G1 and G2 immunoglobulins (23) , which together account for approximately 3% of CP (40, 44) . Thus, in estimating synthesis of protein and of protein plus proteose peptones in the mammary glands, factors of 5.55 and 5.86 were used instead of the conventional 6.38. It was considered that 3.6 g protein was synthesized in the mammary gland per 100 ml milk (3.13 g true protein and .18 g of proteose peptones). Jenness (40) calculated the amino acid (AA) content of proteins in milk synthesized by the mammary gland from the compositions of individual milk proteins. These estimates were adjusted (Table 2 ) to include the proteose peptone fraction but to exclude most minor proteins (e.g., membrane proteins).
Mammary Blood Flow
Mammary blood flow has been estimated by a variety of techniques. Kronfeld et al. (43) used the antipyrene technique to develop the following relationship: Blood flow (liters/ min) --1.0 + .42 x milk yield (kg/day). This equation suggests a blood flow of 700 ml/ml milk ~ produced when daily yield is 15 kg. Although this equation has been used for estimating mammary uptake of nutrients by several workers (24, 26, 28, 76) , many believe it overestimates true blood flow. Reynolds et al. (60) showed that antipyrene overestimated blood flow by 30% as compared to thermodilution. In a comprehensive analysis of the problem, Linzell (47) dismissed the antipyrene technique with the conclusion that in a cow producing a moderate amount of milk, a ratio of 500 ml blood:l ml milk produced would be an appropriate estimate. This was confirmed by Bickerstaffe et al. (19) and Singh and Linzell (63) using thermodilution and urea infusion techniques and Peeters et al. (58) using an electromagnetic technique. A ratio of 500:1 between blood flow and milk yield was used for estimating nutrient uptake in the model. In lactating dairy cows, packed cell volume is approximately 30% (57, 61) . Thus, the ratio flow of blood plasma and milk yield used was 350:1.
Metabolite Uptake
Data on blood and plasma metabolite concentrations, extraction percentages, and uptake by the mammary gland are summarized in Table 3 .
Glucose extraction ranges between 15 and 27% and averages 22% or 11.6 mg/100 ml blood (2, 19, 43, 58, 72, 77, 78) . Extraction percentage of acetate (2, 19, 38, 43, 58, 72, 77) averages 56%, which is equivalent to 5.9 m g/100 ml blood plasma. Betahydroxybutyrate (BHBA) provides 1.6 mg/100 ml blood. Linzell (47) reported 10% of lactate was taken up during passage through the bovine mammary gland. Concentrations of blood lactate are highly variable (69) . The lactate concentration used in model construction (7 mg/100 ml blood) was an average (4, 6, 7, 36, 47, 68) . Arterial propionate concentration is low (7) . The 50% extraction used was based on the report of Bickerstaffe et al. (19) . Uptake of glycerol by the mammary gland has been studied with particular reference to the mech- (40) . Plasma AA concentration averaged from (5, 19, 24, 26, 39, 58, 74) . Extraction percentages were summarized by Clark (24) . Uptake of AA assumes a plasma flux of 350 ml/ml milk produced. Adjusted AA uptake was derived by multiplying uptake of all AA by 1.75; this increase provides 95% milk Tyr + Phe content.
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anism of TG hydrolysis (17, 75) but is not well documented. Bauman and Davis (17) suggested 50% of glycerol in milk TG was derived from blood and 50% synthesized in the gland. This suggestion was adopted in model construction. Reports of TG removal from blood plasma during passage through the mammary gland vary from 11% (32) to 61% (2) with an average of 37% (Table 3 ). Low density lipoprotein fractions carry most TG and are able to release 60 to 80% of their TG (19, 21, 22, 35, 53, 58) . Most reports indicate small, variable, but statistically nonsignificant uptakes of cholesterol esters and phospholipids in cattle (2, 32, 58, 71, 72, 73) and in sheep and goats (15, 46, 50, 75) . Although most summaries suggest the mammary gland does not use lipids from blood other than TG for milk synthesis (53, 67) , most reported arteriovenous (A-V) differences for cholestrol esters and phospholipids are positive and of a magnitude similar to that for TG. It is unlikely that a statistically significant uptake of these lipids could be demonstrated by A-V difference because percentage extraction is so low ( Table 3) .
Extraction of AA from plasma has been measured (19, 24, 26, 28, 58, 66, 74) . Data for individual AA are summarized in Table 2 . Extraction percentages for individual AA range from 5 (glycine) to 69% (glutathione). Uptake of AA is not restricted to those AA appearing in milk proteins as indicated by ornithine and citrulline uptake (Table 2) . auptakes based on assumed blood flow of 500 ml/ml milk and a milk yield of 15 liters/day. Data were for cows producing 9 to 26 kg milk/day average 16 kg; (2, 19, 32, 38, 43, 47, 58, 71, 72, 73, 77) . Amino acid data are from Table 2 . Molar concentrations of TG assume an average FA chain length of 17.55 carbons and a TG molecular weight of 871 daltons. Abbreviations are arteriovenous (A-V), fl-hydroxybutyrate (BHBA), triacylglycerol (TG), cholesterol esters (CE), and nonesterified fatty acids (FFA). day) equivalent to 18.6 ml/ml milk. Peeters et al. (58) reported oxygen uptakes of 17 and 25.6 ml/ml milk in East Flemish cows yielding 14.5 liters milk per day. These data suggest oxygen uptake and CO2 production by the lactating mammary gland are 20 and 21 ml/ml milk at the reported respiratory quotient of 1.05 (19, 58) . These data were the basis for estimating substrate oxidation in the model.
INPUT AND OUTPUT RELATIONSHIPS
Estimates of nutrient uptake by the mammary gland (Table 3 ) are compared with output of milk constituents and carbon dioxide in Table 4 .
Lactose Synthesis
Lactose synthesis requires 88% of glucose taken up by the gland (Table 4 ). The remaining 12% is available for oxidation, conversion to &glycerol-P, and synthesis of other milk components. For the purpose of balancing carbon flux, we assumed that glucose is used for lactose and &glycerol-P synthesis and the remaining (25.48 /amole/ml milk) oxidized (Table 4 ). For simplicity, propionate (9.4 ~tmole/ml milk) was assumed to enter the three carbon metabolite pool with lactate (38.9 /lmole/ml milk), yielding 48.3 /lmole/ml milk for oxidation or milk citrate formation.
Fat Synthesis
AII C18 fatty acids (FA) in milk are derived from plasma lipoproteins, and milk FA with 14 carbons or less are synthesized in the gland (16, 22, 29, 30, 53, 67, 78) . Fatty acids with sixteen carbons are derived from blood plasma TG and are synthesized within the gland. The percentage palmitate synthesized de novo has been estimated at 60 (55), 63 (19) , 55 (35) , and 65% (58) . For this model, it was assumed that 60% of C16 FA and all odd chain (Cls,C17) FA are synthesized within the gland.
This partition of milk FA as to origin implies that 58.9% by weight or 50.2 molar percent of milk FA are preformed and 41.1% by weight are synthesized de novo in accord with (2, 10, 19, 27, 31, 56, 78) . Milk TG molecular weight is 746 dahons, and output is 35 mg/ml milk. Thus, milk is estimated to include 70.6//moles of exogenous FA/mt. Plasma TG can provide (17.7 x 3; Table 3 ) 53.1 gmole FA/ml milk indicating an alternative, exogenous source of C16 and C18 FA. The discrepancy (17.5//moles FA/ml milk) may reflect contributions of other blood lipid fractions. This suggestion is sup-ported by the A-V difference data for cholesterol esters and phospholipids discussed (Table 3) . This issue was avoided in model development by specifying an undefined exogenous pool of fatty acids (ELCFA; Figure 1 ), which supplies sufficient FA to meet the needs of milk fat synthesis (70.6/~moles FA/ml milk).
Precursers for FA synthesized in the mammary gland were considered to be acetate and BHBA. For model construction, we assumed that all C4, C6, Ca, and half of C10 FA are synthesized via essentially a reversal of /3-oxidation, but this occurs in the cytoplasm and requires one NADPH (nicotinamide adenine dinucleotide phosphate, reduced) for reduction of BHBA to butyryt-CoA (coenzyme A) when BHBA supplies the first four carbons (20, 53, 55, 64) and one NADH (nicotinamide adenine dinucleotide, reduced) and one NADPH for the addition of each successive acetyl-CoA unit (17) . Synthesis of other FA was considered to occur via the conventional malonyl-CoA pathway with 60% of the first four carbons originating from BHBA (55) . On this basis, 51.6 /lmole BHBA/ml milk are required for FA synthesis. The remaining 24.09 /2mole were oxidized (Table 4) . De novo FA synthesis requires 302.5 /2mole acetate/ml milk. This leaves 40.5/2moles acetate/ml milk for oxidation (Table 4) , which is considerably below a previous estimate (13) .
Protein Synthesis
The estimate of uptake of AA calculated from blood flow, plasma AA concentration, and percentage extraction data ( Table 2) was 29.2 nag AA/ml milk. This is not sufficient to meet the absolute AA requirements for de novo synthesis of milk protein and proteose peptones (39.65 mg/ml milk) or requirements for most essential AA (EAA; Table 2 ). This discrepancy between estimated uptake of AA and output in milk had to be reconciled.
Several workers reported a near adequate supply of EAA to the lactating mammary gland. One group (24, 25, 26, 28, 66) based their estimates of uptake on estimates from blood flow calculated from the equation of Kronfeld et al. (43) . Other data already discussed indicate that blood flow and, therefore, AA Abbrevlatxons are triacylglyceride (TG), long chain fatty acids (LCFA), fl-hydroxybutyrate (BHBA), extra long chain fatty acids (ELCFA; see text for explanation of discrepancy in LCFA uptake), carbon chain length of FA(C.Ch.), and short chain fatty acids (SCFA). uptake, are likely to be overestimated 30 to 40% by this equation (19, 47, 58, 60, 63) . Peeters et al. (58) reported near adequate AA uptake by the mammary gland. However, the cows in this study yielded milk containing 2.2% protein. This is only two-thirds of typical milk protein content. Mepham (52) discussed estimates of AA uptake from plasma as compared to output in milk with emphasis on deficiencies of methionine, phenylalanine, tyrosine, and tryptophan uptake and raised the possibility that erythrocytes might contribute AA. Heitman and Bergman (37) observed significant uptake of several amino acids from red blood cells by liver. If erythrocyte AA (70) are available to the mammary gland, this could account for most discrepancies. Further research of AA uptake by mammary glands is required.
Because some EAA are oxidized by mammary tissue whereas uptake of others is inadequate for milk protein synthesis (52, Tables 2 and 4), decisions had to be made. Uptake of phenylalanine plus tyrosine from plasma had to be increased 75% to equal output in milk. Because of the empirical nature of this change, the increase was applied to all AA taken up by the mammary gland (Tables 2 and 4) . Net AA uptake then becomes 50.9 mg or 380 ~tmoles/ml milk. Because AA output in milk is 299 ~moles/ ml of AA, a surplus of 81 ~tmoles/ml was created. Because the 75% increase in uptake of all AA was arbitrary, only 50% of this surplus was oxidized in the model (Table 4) .
Origin of Carbon Dioxide
Animal studies have shown 6 and 11% of glucose uptake by the mammary glands of Friesian cows was oxidized to yield 16 and 24% of udder CO2 (2, 19) . These workers also reported that 23 and 29% of acetate taken up was oxidized, yielding 29 and 30% of COs. Only limited in vivo data are available about oxidation of other metabolites.
In vitro studies generally support in vivo findings. Typically, 20 to 30% of labeled acetate appears in COs and the remainder in FA (16, 51, 62) . Glucose oxidation is low (20 to 30%) compared with incorporation into lactose (16, 62 The balance of estimated carbon uptake and output in milk yields a surplus of 604/1moles carbon/ml milk available for oxidation (Table  4 ). This accounts for only two-thirds of reported CO2 yields (937/lmole/mt milk). If BHBA and acetate COo yields are combined, they contribute 19% of observed CO2 output, and glucose oxidation provides 16%. Thirty percent of CO2 can be explained through oxidation of AA and three carbon sources. For model construction we assumed that the additional 333 omoles of carbon required for oxidation originated from the ELCFA pool. This assumption forces uptake and output into balance (Table 4 ; Figure 1 ) and reconciles most available data excepting those on ELCFA and AA uptake, which are greater than reported.
THE BALANCE MODEL
The balance model in Figure 1 is based on considerations of input and output discussed above and is in accord with biochemical pathways. Estimated oxidation, as indicated by COz yield and respiratory quotient (RQ), was essential to determination of both NADPH and adenosine triphosphate (ATP) synthesis by the udder. Milk synthesis required 72 moles of high energy phosphate bonds (~ P) per day, which accounted for 76% of ~ P yield from substrate oxidation. De novo fat synthesis requires 9.0 moles NADPH/day in a cow yielding 15 liters milk. Pentose cycle generation of NADPH is governed by glucose uptake, utilization for lactose and aGP synthesis, and constraints on glucose-6-phosphate (G6P) precursors. Yield of NADPH2 via this pathway in the model is 3.8 /lmoles/day. Formation of NADPH2 via cytosolic isocitrate dehydrogenase is 5.2 ~tmoles/day. This is 98% of the citrate to a-ketogluturate (aKG) flux, which is constrained to udder CO2 production (14 moles/day). Although NADPH requirements are satisfied in this representation, it is unlikely that potential NADPH generation would be as limited as depicted. A small increase of glucose uptake from 4.71 to 5.21 moles/day would raise pentose NADPH generating capacity to 8.8 moles/day, sufficient to supply nearly all needs for de novo FA synthesis. Also, it is unlikely that the entire flux between isocitrate and &KG is extra mitochondrial even though the maximum velocity (Vmax) of the cytosolic NADPH isocitrate dehydrogenase is extremely high (Table 5) .
Mammary Gland Enzyme Activities and Metabolite Pool Sizes
Two additional types of data were required to convert the balance model to a dynamic model. Enzyme data were required to provide guidance in specifying forward versus reverse velocities for reversible reactions as only net aAll data are expressed in terms of wet tissue corrected where necessary to 37°C. Data previously expressed in terms of tissue nitrogen have been recalculated for 55 mg protein/g tissue (54) and 10 mg mitochondrial protein/g tissue. Abbrevations are: uridine diphosphate (UDP), phosphate (P), phosphoenolpyruvate (PEP), and 13-hydroxybutyrate (BHBA). bm = Mitochondrial, c = cytosolar. fluxes are represented in the balance model. This is essential to correct simulation of radioisotope tracer data. Tissue metabolite pool sizes were required for computation of rate constants.
Enzyme activities in Table 5 were calculated from in vitro determinations of Vma x. When possible, data were for cows close to midlactation. Enzyme Vmax usually exceed estimated fluxes in Figure 1 several fold. For example, enzymes for lactose synthesis, other than lactose synthetase, are considerably in excess of requirements. Other particularly active enzymes are NADP isocitrate dehydrogenase, NAD malate dehydrogenase, hexose-P isomerase, and aspartate aminotransferase. Pyruvate dehydrogenase activity is low, suggesting limited capacity for oxidation of pyruvate in the gland. Citrate cleavage and NADP malate dehydrogenase activities are also low.
Concentrations of metabolites or pool sizes are needed for model solution. These are in Table 6 . Pool sizes are expressed either in terms of intracellular (80% of udder weight) or extracellular space (20% of udder weight). Blood and plasma metabolites were assumed to be in rapid equilibrium with the extracellular compartment so that blood or plasma concentrations (Table 3) could be used to calculate extracellular pool sizes. Intracellular pool sizes are based primarily on data summarized by Baldwin and Yang (13) with corrections applied where necessary to ensure intra-and extracellular pools are separated.
THE DYNAMIC MODEL
The dynamic model was written for the KINSYM modeling system developed by Garfinkel (34) . In this system, input is in the form of chemical equations: 
where k(1) and k(2) are rate constants calculated from the flux specified as input:
The KINSYM system then solves the difo ference equations over time (D(A)/dt). When the model is in steady state, as in Figure 1 , synthetic rates, etc. do not change during solution. However, when the model is perturbed by changing, for example, blood metabolite concentrations, the pool sizes and fluxes change over time until a new steady state is attained.
RADIOISOTOPE TRACER MODEL
Substrates labeled with radioisotopes frequently are used to investigate biochemical pathways in and kinetic properties of tissues. Numerous workers have proposed formulae for interpretation of radioisotope data (41) . These formulae have proven to be highly useful. However, the several formulae often yield incompatible estimates of the relative contributions of alternate pathways (41) . Important causes of differing estimates appear to be failure to attain isotope equilibration in reversible reactions and diversion of carbon via pathways not considered in development of the formulae (41) . Ruminant animals pose a particularly acute problem. Most formulae assume that the primary route of utilization of pyruvate formed from glucose is oxidation via pyruvate dehydrogenase and the tricarboxylic acid pathway or conversion to fatty acids. In these species, acetate is the primary carbon aAla concentration assumes alanine aminotransferase equilibrium (14) . bGland concentration assumed equal to plasma concentration.
Cco 2 pool assumes equilibration with dissolved blood CO x (1, 49) . Pool sizes for NAD, NADH, NADP, NADPH, FAD, FADH, RU5P were set at 2.0 mmoles/udder. source for oxidation and fatty acid synthesis, and pyruvate is only a minor contributor. Two problems confront the investigator of ruminant tissue metabolism: what radioisotope tracers should be used to study contributions of alternate pathways and how the data can be interpreted.
Our objective was to develop a radioisotope tracer model suitable for the identification of critical experiments and measurements. This process is illustrated for the hexokinase and P-hexose isomerase reactions in Table 7 . Development of the tracer model is reasonably straightforward, given a working dynamic model, even though the tracer model is several times larger, because transactions must be accounted for carbon by carbon rather than molecule by molecule. The tracer model is written such that, in the absence of an endogenous, unlabeled source of G6P or fuctose-6-phosphate (F6P), the specific activities of G6P* and F6P* at steady state (calculated as the sum of all labeled G6P/unlabeled G6P and all labeled F6P/unlabeled F6P) would be .01 as specified as input for the tracer substrates.
When the equations in Table 7 are interfaced with those required to represent the pentose cycle, G6PI* metabolized via this path would yield unlabeled F6P, and specific activities of F6PI* and G6PI* would be less than .01. The exact specific activities of G6PI* and F6PI* at steady state would depend upon rate of lactose synthesis, pentose cycle flux, Embden-Meyerhof pathway flux, and whether isotopic equilibrium is achieved in the P-hexose isomerase reaction. Similarly, relative rates of incorporation of labeled carbon from GLCI* into lactose, CO2, triacylglyceride glycerol, and other products would vary dependent upon rate of lactose synthesis, pentose cycle flux, glycolytic flux, and degree of isotopic equilibrium at P-hexose isomerase.
Simulation analyses of milk synthesis, using isotopically labeled substrates, showed that a minimum of 8 to 16 rate constants (F(i) = K i *Si) are required to define fluxes associated with lactose synthesis, the pentose cycle, and glycolysis. These included reactions of hexokinase, lactose synthetase, glucose-6-P dehydrogenase, phosphofructokinase, triglyceride synthetase, and glyceraldehyde-3-P dehydrogenase and the forward and reverse reactions of P-hexose isomerase, and, possibly, P-glucomutase, uridine diphosphate (UDP) glucose pyrophosphorylase, UDP galactose-4-epimerase, and triose-P-isomerase. Several but certainly not all of these can be defined for a given animal or experiment by measuring glucose uptake and oxidation, lactose, and triacylglycerol synthesis, etc. (1-14C-glucose (GLCI*) of U-14C-glucose (GLCU*)) used is set to .01 of the pool size specified in the dynamic model so transactions in the tracer model do not significantly affect co-metabolite (e.g. ATP) pool sizes during solution. Initial values of other labeled species are automatically set to 1.0E-9 and achieve steady state during solution. Left parentheses indicate fluxes and slashes indicate rate constants (see text). Rate constants are those used during solution of dynamic model (see text). Number followed by asterisk (*) indicates position of labeled carbon in each metabolite. Other notations are glucose-6-P (G6P), glucose (GLC), and fructose-6-P (F6P). bAbbreviations are glucose (GLC), alanine (ALA), lactate (LAC), acetate (AC), and glutamate (GLU). Numbers indicate specific carbon labeled and U indicates uniformly labeled.
CResponse variables are rate of conversion of labeled carbons to products at steady state. Minus signs indicate responses to Flux changes were less than 3%. Arrows indicate directions of responses observed.
Two major questions arose from our attempts to simulate tracer kinetics. 1) Which rate constants significantly influence the distribution of labeled carbons among products? 2) What experimental measurements are required to define uniquely the unknown rate constant? Sensitivity analyses were done using the radioisotope model as a first step toward addressing these questions.
Example results of the sensitivity analyses are in Table 8 . These analyses showed variations of rates of equilibration at P-glucomutase, UDP glucose pyrophosphorylase, and UDP galactose-4-epimerase did not influence patterns of tracer distribution among products.
This result allowed simplification of the representation of the pathway of lactose synthesis to UTP + G6P ~ UDPgal UDPgal + GLC ~ lactose (where UPT codes uridine triphosphate and GLC codes glucose.) Similarly, exact specification of rate constants for lactic dehydrogenase (Table 8) , NAD malate dehydrogenase, and several other enzymes was not necessary, because as long as net flux is specified correctly, rate constants do not influence tracer distribution.
Simulation and other analyses have shown that rate constants can be defined uniquely for the following metabolic fluxes and enzymes in the mammary gland: lactose synthesis; pentose cycle; phosphofructokinase; ~GP formation; exchange and net flux of tracers between tricarboxylic acid cycle intermediates and the triosephosphates; pyruvate dehydrogenase; pyruvate carboxylase; phosphoenolpyruvate carboxykinase, malate dehydrogenase, citrate synthetase; isoeitrate dehydrogenase, aspartate, alanine, and glutamate aminotransferases, and adenosine triphosphate-citrate lyase. Definition is dependent on measurement of glucose uptake, lactose, protein, and fat synthesis and involves the following substrates: U-,I-,2-, and 6A~C-glucose, 2A4-C-glycerol, 2-14C-aspartate 14CO2, 2-14C-alanine, 23aC-glutamate, 2-14C -acetate, and 2-14C-fl-hydroxybutyrate, and determination of specific activities of the following products: CO2, triacylglyceride glycerol, lactose, short and medium chain length FA, and citrate. These analyses are not presented in detail, because one significant problem must be overcome before the analyses can be completed. Baldwin et al. (11) summarized a number of A-V difference data that indicated that uptakes of several blood metabolites by cow mammary tissue followed essentially Michaelis-Menten type kinetics. When a range of blood metabolite concentrations were specified as input to the current model in the course of sensitivity analyses, comparable patterns of metabolite uptake were not obtained. This result indicates that the assumption of mass action kinetics that was used in formulating equations of the current model is inadequate. More complex kinetic arguments must be introduced for some reactions. Data available in the literature upon completion of this study were not adequate either to identify the reactions for which more complex kinetic representations are required or to formulate appropriate equations. Experiments required to overcome this problem have been completed.
